Boston Scientific Corporation

Boston Scientific

BSX · NYSE

Healthcare

Catalog as of September 15, 2026. Not a live market feed.

Fiscal Year: 2025
Revenue: $20.1B
Assets: $43.7B
SEC filing: DEF 14A
Filed: March 18, 2026

Executive Compensation

Compensation reported for Boston Scientific’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.

Named executive officer compensation
Executive	Position	Salary	Stock Awards	Incentives	Option Awards	Other	Reported total
Michael F. Mahoney	Chairman Of The Board, President And Chief Executive Officer	$1,442,603	$13,608,056	$4,002,001	$3,749,980	$729,410	$23,532,050
Joseph M. Fitzgerald	Executive Vice President And Group President, Cardiovascular	$892,604	$4,309,282	$1,458,001	$1,187,463	$195,647	$8,042,997
Arthur C. Butcher	Executive Vice President And Group President, Med Surg And Asia Pacific	$744,822	$3,447,272	$1,012,501	$949,962	$380,162	$6,534,719
Daniel J. Brennan	Former Executive Vice President And Chief Financial Officer	$660,990	$3,447,272	$1,098,004	$949,962	$126,668	$6,282,896
Jonathan R. Monson	Executive Vice President And Chief Financial Officer	$591,848	$1,624,898	$840,000	$1,170,504	$1,856,429	$6,083,679
Jeffrey B. Mirviss	Executive Vice President And President, Peripheral Interventions	$702,042	$1,995,566	$793,126	$549,989	$119,236	$4,159,959
Vance R. Brown	Senior Vice President, General Counsel And Corporate Secretary	$659,086	$1,723,636	$897,751	$474,960	$165,211	$3,920,644

Michael F. Mahoney
Chairman Of The Board, President And Chief Executive Officer
$23.5M
Reported total
Salary
$1,442,603
Stock awards
$13,608,056
Incentives
$4,002,001
Option awards
$3,749,980
Other
$729,410
Joseph M. Fitzgerald
Executive Vice President And Group President, Cardiovascular
$8M
Reported total
Salary
$892,604
Stock awards
$4,309,282
Incentives
$1,458,001
Option awards
$1,187,463
Other
$195,647
Arthur C. Butcher
Executive Vice President And Group President, Med Surg And Asia Pacific
$6.5M
Reported total
Salary
$744,822
Stock awards
$3,447,272
Incentives
$1,012,501
Option awards
$949,962
Other
$380,162
Daniel J. Brennan
Former Executive Vice President And Chief Financial Officer
$6.3M
Reported total
Salary
$660,990
Stock awards
$3,447,272
Incentives
$1,098,004
Option awards
$949,962
Other
$126,668
Jonathan R. Monson
Executive Vice President And Chief Financial Officer
$6.1M
Reported total
Salary
$591,848
Stock awards
$1,624,898
Incentives
$840,000
Option awards
$1,170,504
Other
$1,856,429
Jeffrey B. Mirviss
Executive Vice President And President, Peripheral Interventions
$4.2M
Reported total
Salary
$702,042
Stock awards
$1,995,566
Incentives
$793,126
Option awards
$549,989
Other
$119,236
Vance R. Brown
Senior Vice President, General Counsel And Corporate Secretary
$3.9M
Reported total
Salary
$659,086
Stock awards
$1,723,636
Incentives
$897,751
Option awards
$474,960
Other
$165,211

Michael F. Mahoney

Chairman Of The Board, President And Chief Executive Officer

$23.5M

Reported total · FY2025 · SCT Total as filed

Source: DEF 14A Summary Compensation Table, filed March 18, 2026.

Salary: $1.4M
Stock Awards: $13.6M
Option Awards: $3.7M
Incentives: $4M
Other: $729K

Historical Compensation

Michael F. Mahoney total compensation, fiscal years 2023–2025.

Year-by-year total compensation
Fiscal Year	Salary	Stock Awards	Total Compensation
2025	$1,442,603	$13,608,056	$23,532,050
2024	$1,400,000	$12,229,998	$21,420,801
2023	$1,400,000	$10,472,753	$18,723,735

Named Executive Officers

Michael F. Mahoney

Chairman Of The Board, President And Chief Executive Officer

Boston Scientific · BSX

$23.5M

FY 2025 · DEF 14A

Jonathan R. Monson

Executive Vice President And Chief Financial Officer

Boston Scientific · BSX

$6.1M

FY 2025 · DEF 14A

Vance R. Brown

Senior Vice President, General Counsel And Corporate Secretary

Boston Scientific · BSX

$3.9M

FY 2025 · DEF 14A

Arthur C. Butcher

Executive Vice President And Group President, Med Surg And Asia Pacific

Boston Scientific · BSX

$6.5M

FY 2025 · DEF 14A

Joseph M. Fitzgerald

Executive Vice President And Group President, Cardiovascular

Boston Scientific · BSX

$8M

FY 2025 · DEF 14A

Daniel J. Brennan

Former Executive Vice President And Chief Financial Officer

Boston Scientific · BSX

$6.3M

FY 2025 · DEF 14A

Jeffrey B. Mirviss

Executive Vice President And President, Peripheral Interventions

Boston Scientific · BSX

$4.2M

FY 2025 · DEF 14A

Source information

Company: Boston Scientific Corporation
Ticker: BSX · NYSE
Filing type: DEF 14A
Fiscal year: 2025
Filing date: March 18, 2026
SEC accession number: 0000885725-26-000025

Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing

Related Companies

Johnson & Johnson

JNJ · NYSE

Joaquin Duato

Chairman/CEO

$32.8M

FY 2025 reported total

View company →

UnitedHealth

UnitedHealth Group Incorporated

UNH · NYSE

Stephen Hemsley

Chief Executive Officer

$60.9M

FY 2025 reported total

View company →

AbbVie

AbbVie Inc.

ABBV · NYSE

Robert A. Michael

Chairman Of The Board And Chief Executive Officer

$32.5M

FY 2025 reported total

View company →

Abbott

Abbott Laboratories

ABT · NYSE

Robert B. Ford

Chairman Of The Board And Chief Executive Officer

$24.2M

FY 2025 reported total

View company →